AG˹ٷ

STOCK TITAN

[Form 4] Healthpeak Properties, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Healthpeak Properties (DOC) Form 4: President & CEO Scott M. Brinker purchased 1,490 common shares on 08/04/2025 at $16.83, an outlay of roughly $25k. Post-transaction direct ownership rises to 211,906 shares. No derivative trades were reported. The filing reflects routine insider buying and does not alter control status; Brinker remains both a director and executive officer.

Healthpeak Properties (DOC) Modulo 4: Il Presidente e CEO Scott M. Brinker ha acquistato 1.490 azioni ordinarie il 04/08/2025 a $16,83, per un investimento di circa $25.000. Dopo l'operazione, la proprietà diretta sale a 211.906 azioni. Non sono state segnalate operazioni su derivati. La comunicazione riflette un acquisto interno di routine e non modifica lo status di controllo; Brinker rimane sia direttore che dirigente.

Healthpeak Properties (DOC) Formulario 4: El Presidente y CEO Scott M. Brinker compró 1,490 acciones ordinarias el 04/08/2025 a $16.83, por un desembolso aproximado de $25,000. Tras la transacción, la propiedad directa aumenta a 211,906 acciones. No se reportaron operaciones con derivados. La presentación refleja una compra rutinaria por parte de un insider y no altera el control; Brinker sigue siendo director y ejecutivo.

Healthpeak Properties (DOC) Form 4: 사장 � CEO 스콧 M. 브링커가 2025� 8� 4일에 보통� 1,490주를 주당 $16.83� � $25,000 상당� 매입했습니다. 거래 � 직접 보유 주식은 211,906주로 증가했습니다. 파생상품 거래� 보고되지 않았습니�. � 신고� 일상적인 내부� 매입� 반영하며 지배권 상태에는 변동이 없으�, 브링커는 여전� 이사 � 임원직을 유지하고 있습니다.

Healthpeak Properties (DOC) Formulaire 4 : Le président et CEO Scott M. Brinker a acheté 1 490 actions ordinaires le 04/08/2025 au prix de 16,83 $, pour un investissement d'environ 25 000 $. Après la transaction, la détention directe s'élève à 211 906 actions. Aucune opération sur dérivés n'a été signalée. Le dépôt reflète un achat interne de routine et ne modifie pas le statut de contrôle ; Brinker reste à la fois directeur et cadre dirigeant.

Healthpeak Properties (DOC) Formular 4: Präsident und CEO Scott M. Brinker erwarb am 04.08.2025 1.490 Stammaktien zu je 16,83 USD, was einem Aufwand von etwa 25.000 USD entspricht. Nach der Transaktion erhöht sich der direkte Besitz auf 211.906 Aktien. Es wurden keine Derivatgeschäfte gemeldet. Die Meldung spiegelt einen routinemäßigen Insiderkauf wider und ändert nichts am Kontrollstatus; Brinker bleibt sowohl Direktor als auch Führungskraft.

Positive
  • Insider confidence: CEO purchased shares on the open market, signalling a personal bullish view.
  • Ownership increase: Post-transaction stake rises to 211,906 shares, aligning management further with shareholders.
Negative
  • Immaterial size: Only 1,490 shares (~$25k) limits the transaction’s significance.
  • No strategic information: Filing lacks guidance or operational updates, offering little insight into fundamentals.

Insights

TL;DR: Small CEO buy is mildly bullish but not thesis-changing.

The P-code purchase, though positive for sentiment, represents under 1% of Brinker's existing stake and an immaterial cash amount for a $16 bn+ REIT. Insider buying after the recent pullback suggests confidence in valuation and upcoming fundamentals, yet the scale limits predictive power for earnings or NAV trajectory. Investors may view it as an incremental vote of confidence rather than a catalyst.

Healthpeak Properties (DOC) Modulo 4: Il Presidente e CEO Scott M. Brinker ha acquistato 1.490 azioni ordinarie il 04/08/2025 a $16,83, per un investimento di circa $25.000. Dopo l'operazione, la proprietà diretta sale a 211.906 azioni. Non sono state segnalate operazioni su derivati. La comunicazione riflette un acquisto interno di routine e non modifica lo status di controllo; Brinker rimane sia direttore che dirigente.

Healthpeak Properties (DOC) Formulario 4: El Presidente y CEO Scott M. Brinker compró 1,490 acciones ordinarias el 04/08/2025 a $16.83, por un desembolso aproximado de $25,000. Tras la transacción, la propiedad directa aumenta a 211,906 acciones. No se reportaron operaciones con derivados. La presentación refleja una compra rutinaria por parte de un insider y no altera el control; Brinker sigue siendo director y ejecutivo.

Healthpeak Properties (DOC) Form 4: 사장 � CEO 스콧 M. 브링커가 2025� 8� 4일에 보통� 1,490주를 주당 $16.83� � $25,000 상당� 매입했습니다. 거래 � 직접 보유 주식은 211,906주로 증가했습니다. 파생상품 거래� 보고되지 않았습니�. � 신고� 일상적인 내부� 매입� 반영하며 지배권 상태에는 변동이 없으�, 브링커는 여전� 이사 � 임원직을 유지하고 있습니다.

Healthpeak Properties (DOC) Formulaire 4 : Le président et CEO Scott M. Brinker a acheté 1 490 actions ordinaires le 04/08/2025 au prix de 16,83 $, pour un investissement d'environ 25 000 $. Après la transaction, la détention directe s'élève à 211 906 actions. Aucune opération sur dérivés n'a été signalée. Le dépôt reflète un achat interne de routine et ne modifie pas le statut de contrôle ; Brinker reste à la fois directeur et cadre dirigeant.

Healthpeak Properties (DOC) Formular 4: Präsident und CEO Scott M. Brinker erwarb am 04.08.2025 1.490 Stammaktien zu je 16,83 USD, was einem Aufwand von etwa 25.000 USD entspricht. Nach der Transaktion erhöht sich der direkte Besitz auf 211.906 Aktien. Es wurden keine Derivatgeschäfte gemeldet. Die Meldung spiegelt einen routinemäßigen Insiderkauf wider und ändert nichts am Kontrollstatus; Brinker bleibt sowohl Direktor als auch Führungskraft.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brinker Scott M

(Last) (First) (Middle)
4600 SOUTH SYRACUSE STREET
SUITE 500

(Street)
DENVER CO 80237

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/04/2025 P 1,490 A $16.83 211,906 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Carol Samaan, SVP, Legal (Attorney-In-Fact) 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Healthpeak (DOC) shares did the CEO buy?

Scott M. Brinker bought 1,490 common shares.

What was the purchase price disclosed in the Form 4?

The shares were acquired at $16.83 each.

What is the CEO's total direct ownership after the transaction?

Brinker now directly owns 211,906 DOC shares.

Was this an open-market purchase or an option exercise?

The transaction code "P" indicates an open-market purchase.

Did the Form 4 report any derivative security activity?

No derivative securities were acquired or disposed of in this filing.
Healthpeak Properties Inc

NYSE:DOC

DOC Rankings

DOC Latest News

DOC Latest SEC Filings

DOC Stock Data

11.65B
692.76M
0.29%
98.19%
2.76%
REIT - Healthcare Facilities
AG˹ٷ Estate Investment Trusts
United States
DENVER